Yu Xingxi 余兴喜
Companies 任职公司
| Company 公司 | Industry 行业 | Role 职务 | Since 起始 | Grade 评级 |
|---|---|---|---|---|
| Beijing Shougang 首钢股份 | Ordinary Steel | Independent Director | 23 Dec 2025 | C |
| China National Medicines 国药股份 | Pharmaceutical Distribution | Independent Director | 7 Apr 2022 | C |
Biography 简历
余兴喜:独立董事研究生学历,管理学硕士,高级会计师。曾任铁10师46团新兵1连战士,铁道兵青藏线(副营)会计师,铁10师新管处财务科会计师,铁20局建工处(正科)副总会,铁20局建工处总会、会计师,中国铁道建筑总公司财务部总会、高会,中国铁道建筑总公司财务部副部长、资金结算中心主任、高会,中国铁道建筑总公司财务部部长、高会,中国铁建股份有限公司财务部部长、高会,中国铁建股份有限公司董事会秘书、联席公司秘书、新闻发言人、高会,北京上市公司协会秘书长兼任北京交通大学经管学院兼职教授、瑞泰科技股份有限公司独立董事、北京科锐国际股份有限公司独立董事、国药集团药业股份有限公司独立董事。现任瑞泰科技股份有限公司独立董事,国药集团药业股份有限公司独立董事。2022年12月23日任首钢股份独立董事。
English Translation 英文译文 · Organisation Names in Chinese 机构名称保留中文Yu Xingxi: Independent Director with a postgraduate education, master's degree in management, and a senior accountant. He served as a soldier in the 1st Company of the 46th Regiment of the 10th Railway Engineering Regiment, an accountant in the Qinghai-Tibet Line (deputy battalion) of the Railway Troops, an accountant in the Finance Department of the New Management Office of the 10th Railway Engineering Regiment, deputy chief accountant and chief accountant of the Construction Department of the 20th Railway Bureau, chief accountant of the Construction Department of the 20th Railway Bureau, chief accountant and senior accountant of the Finance Department of 中国铁道建筑总公司, deputy director and head of the Fund Settlement Center of the Finance Department of 中国铁道建筑总公司, chief accountant of the Finance Department of 中国铁道建筑总公司, chief accountant of the Finance Department of 中国铁建股份有限公司 (China Railway Construction), secretary of the board of directors of 中国铁建股份有限公司 (China Railway Construction), secretary of 联席公司, spokesperson, senior accountant, secretary-general of 北京上市公司协会 and concurrently part-time professor of 北京交通大学经管学院, independent director of 瑞泰科技股份有限公司 (Ruitai Materials Technology), independent director of 北京科锐国际股份有限公司, and independent director of 国药集团药业股份有限公司 (China National Medicines). Currently serves as an independent director of 瑞泰科技股份有限公司 (Ruitai Materials Technology) and 国药集团药业股份有限公司 (China National Medicines). On December 23, 2022, he was appointed as an independent director of 首钢股份 (Beijing Shougang).